Статья

Presence of viremia during febrile neutropenic episodes in patients undergoing chemotherapy for malignant neoplasms

K. Obrová, S. Grumaz, M. Remely, S. Czurda, I. Krickl, S. Herndlhofer, K. Gleixner, W. Sperr, L. Größlinger, T. Frank, N. Andrade, T. Egger‐Matiqi, C. Peters, G. Engstler, M. Dworzak, A. Attarbaschi, M. Grotel, M. Heuvel‐Eibrink, I. Moiseev, Y. Rogacheva, L. Zubarovskaya, N. Zubarovskaya, H. Pichler, A. Lawitschka, E. Koller, F. Keil, P. Valent, K. Sohn, T. Lion,
2021

The importance of viral infections as a leading cause of morbidity and mortality is well documented in severely immunosuppressed patients undergoing allogeneic stem cell transplantation. By contrast, viral infections generally receive less attention in patients with malignant disorders undergoing chemotherapy, where the onset of neutropenic fever is mostly associated with bacterial or fungal infections, and screening for viral infections is not routinely performed. To address the occurrence of invasive viral infections in a clinical setting commonly associated with less pronounced immunosuppression, we have prospectively screened 237 febrile neutropenic episodes in pediatric (n = 77) and adult (n = 69) patients undergoing intensive chemotherapy, primarily for treatment of acute leukemia. Serial peripheral blood specimens were tested by RQ-PCR assays for the presence and quantity of the clinically relevant viruses CMV, EBV, HHV6 and HAdV, commonly reactivated in highly immunocompromised patients. Viremia was documented in 36 (15%) episodes investigated, including the detection of HHV6 (n = 14), EBV (n = 15), CMV (n = 6), or HAdV (n = 1). While low or intermediate levels of viremia (<104 virus copies/mL) were commonly associated with bacterial or fungal co-infection, viremia at higher levels (>104 copies/mL) was documented in patients without evidence for other infections, raising the possibility that at least in some instances the onset of fever may have been attributable to the virus detected. The observations suggest that viral infections, potentially resulting from reactivation, might also play a clinically relevant role in patients receiving chemotherapy for treatment of malignant neoplasms, and routine screening for viremia in this clinical setting might be warranted.

Цитирование

Похожие публикации

Версии

  • 1. Version of Record от 2021-05-03

Метаданные

Об авторах
  • K. Obrová
    St.Anna Children's Cancer Research Institute (CCRI), Vienna, Austria
  • S. Grumaz
    Fraunhofer IGB, Stuttgart, Germany
  • M. Remely
    St.Anna Children's Cancer Research Institute (CCRI), Vienna, Austria
  • S. Czurda
    St.Anna Children's Cancer Research Institute (CCRI), Vienna, Austria
  • I. Krickl
    St.Anna Children's Cancer Research Institute (CCRI), Vienna, Austria
  • S. Herndlhofer
    Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria
  • K. Gleixner
    Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria, Ludwig Boltzmann Institute for Hematology & Oncology, Medical University of Vienna, Vienna, Austria
  • W. Sperr
    Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria, Ludwig Boltzmann Institute for Hematology & Oncology, Medical University of Vienna, Vienna, Austria
  • L. Größlinger
    Labdia Labordiagnostik GmbH, Vienna, Austria
  • T. Frank
    St.Anna Children's Cancer Research Institute (CCRI), Vienna, Austria
  • N. Andrade
    St.Anna Children's Cancer Research Institute (CCRI), Vienna, Austria
  • T. Egger‐Matiqi
    St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria
  • C. Peters
    St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria
  • G. Engstler
    St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria
  • M. Dworzak
    St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria
  • A. Attarbaschi
    St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria
  • M. Grotel
    Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
  • M. Heuvel‐Eibrink
    Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
  • I. Moiseev
    I. P. Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia
  • Y. Rogacheva
    I. P. Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia
  • L. Zubarovskaya
    I. P. Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia
  • N. Zubarovskaya
    St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria
  • H. Pichler
    St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria
  • A. Lawitschka
    St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria
  • E. Koller
    3rd Medical Department, Hanuschhospital, Vienna, Austria
  • F. Keil
    Ludwig Boltzmann Institute for Hematology & Oncology, Medical University of Vienna, Vienna, Austria, 3rd Medical Department, Hanuschhospital, Vienna, Austria
  • P. Valent
    Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria, Ludwig Boltzmann Institute for Hematology & Oncology, Medical University of Vienna, Vienna, Austria
  • K. Sohn
    Fraunhofer IGB, Stuttgart, Germany
  • T. Lion
    St.Anna Children's Cancer Research Institute (CCRI), Vienna, Austria, Ludwig Boltzmann Institute for Hematology & Oncology, Medical University of Vienna, Vienna, Austria, Labdia Labordiagnostik GmbH, Vienna, Austria, Department of Pediatrics, Medical University of Vienna, Vienna, Austria
Название журнала
  • American Journal of Hematology
Том
  • 96
Выпуск
  • 6
Страницы
  • 719-726
Издатель
  • Wiley
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC BY
Правовой статус документа
  • Свободная лицензия
Источник
  • dimensions